Sino Medical Sciences Technology Inc. (SHA: 688108), a China-based medical technology company, has announced that the National Medical Products Administration (NMPA) has accepted for review its marketing approval filing for a self-expanding intracranial drug-coated stent system.
Designed for the treatment of intracranial atherosclerotic stenosis, the product is intended to support and dilate the lumen of stenotic and obstructive blood vessels, thereby improving the diameter of the intracranial artery lumen and addressing cerebral ischemia. The company states that this is the world’s first self-expanding nickel titanium alloy drug-coated stent specifically developed for intracranial atherosclerotic stenosis. It features a microcatheter delivery system and a unique grid structure that carries rapamycin drugs, effectively reducing cytotoxicity. These attributes are designed to decrease the occurrence of stent restenosis and recurrent strokes, ensuring safety, non-neurotoxicity, and enhancing surgical safety, the navigability of the stent in tortuous blood vessels, and the convenience of surgical procedures.- Flcube.com
